Literature DB >> 21351312

Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database.

Vicky Tagalakis1, Susan R Kahn.   

Abstract

PURPOSE: To determine the test characteristics of diagnostic codes within a medical service claims database for deep vein thrombosis (DVT) and pulmonary embolism (PE).
METHODS: The Regie de l' Assurance Maladie du Québec (RAMQ) administers the health insurance program in Québec, Canada. RAMQ claims data were obtained for subjects with objectively diagnosed DVT with or without PE who were participants in the Venous Thrombosis Outcomes (VETO) Study from April 2001 to July 2002. Using the date of DVT and PE diagnosis in the VETO record as the reference standard, the proportion of subjects correctly classified by RAMQ diagnostic codes was determined for the exact date of DVT and PE occurrence and for four expanded time windows around this date.
RESULTS: In all, 355 VETO patients were included, 301 with DVT alone and 54 with DVT and PE. Overall, 97% of VETO cases had a RAMQ diagnostic code for DVT and 82% of VETO cases with PE had a RAMQ diagnostic code for PE. Sensitivity for DVT and PE was 52% (95% confidence interval (CI), 47-57) and 35% (95% CI, 23-49), respectively for the exact date of diagnosis, and 87% (95% CI, 83-90) and 78% (95% CI, 64-88), respectively for a 60-day window around this date. As all VETO participants had DVT, specificity for the diagnosis of DVT could not be determined.
CONCLUSION: Diagnostic codes within a medical service claims database are relatively sensitive indicators for DVT and PE, and use of claims data for VTE research purposes can be considered.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21351312     DOI: 10.1002/pds.2061

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  13 in total

1.  Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.

Authors:  Seoyoung C Kim; Daniel H Solomon; Jun Liu; Jessica M Franklin; Robert J Glynn; Sebastian Schneeweiss
Journal:  Am J Med       Date:  2014-12-20       Impact factor: 4.965

2.  Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer.

Authors:  Thomas Delate; Daniel M Witt; Debra Ritzwoller; Jane C Weeks; Lawrence Kushi; Mark C Hornbrook; Erin J Aiello Bowles; Deborah Schrag
Journal:  Oncologist       Date:  2012-02-14

3.  Loss of Pulmonary Vascular Volume as a Predictor of Right Ventricular Dysfunction and Mortality in Acute Pulmonary Embolism.

Authors:  Jasleen Minhas; Pietro Nardelli; Syed Moin Hassan; Nadine Al-Naamani; Eileen Harder; Samuel Ash; Gonzalo Vegas Sánchez-Ferrero; Stefanie Mason; Andetta R Hunsaker; Gregory Piazza; Samuel Z Goldhaber; Aaron B Waxman; Steven M Kawut; Raúl San José Estépar; George R Washko; Farbod N Rahaghi
Journal:  Circ Cardiovasc Imaging       Date:  2021-09-21       Impact factor: 8.589

4.  Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates.

Authors:  Steven M Brunelli; Joshua J Gagne; Krista F Huybrechts; Shirley V Wang; Amanda R Patrick; Kenneth J Rothman; John D Seeger
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-03-22       Impact factor: 2.890

5.  Risk of venous thromboembolism in patients with rheumatoid arthritis.

Authors:  Seoyoung C Kim; Sebastian Schneeweiss; Jun Liu; Daniel H Solomon
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-10       Impact factor: 4.794

6.  Effectiveness of a novel and scalable clinical decision support intervention to improve venous thromboembolism prophylaxis: a quasi-experimental study.

Authors:  Craig A Umscheid; Asaf Hanish; Jesse Chittams; Mark G Weiner; Todd E H Hecht
Journal:  BMC Med Inform Decis Mak       Date:  2012-08-31       Impact factor: 2.796

7.  Morbidity and mortality of women and men with intellectual and developmental disabilities newly initiating antipsychotic drugs.

Authors:  Simone N Vigod; Yona Lunsky; Virginie Cobigo; Andrew S Wilton; Sarah Somerton; Dallas P Seitz
Journal:  BJPsych Open       Date:  2016-04-20

8.  Limitations of pulmonary embolism ICD-10 codes in emergency department administrative data: let the buyer beware.

Authors:  Kristin Burles; Grant Innes; Kevin Senior; Eddy Lang; Andrew McRae
Journal:  BMC Med Res Methodol       Date:  2017-06-08       Impact factor: 4.615

9.  Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with aortic aneurysms: A nationwide cohort study.

Authors:  Feng-You Lee; Wei-Kung Chen; Chun-Hsiang Chiu; Cheng-Li Lin; Chia-Hung Kao; Chao-Hsien Chen; Tse-Yen Yang; Ching-Yuan Lai
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

10.  Prevalence of venous thromboembolism in admissions and readmissions with and without syncope: a nationwide cohort study.

Authors:  Amer N Kadri; Misam Zawit; Raed Al-Adham; Ismail Hader; Leen Nusairat; Mohamed F Almahmoud; Mourad Senussi; Ahmed Altibi; Amr Barakat; Adrian V Hernandez; Ahmad Masri
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2021-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.